Pharmacyte Biotech Stock Price on November 4, 2024
| PMCB Stock | USD 1.76 0.01 0.57% |
If you're considering investing in PharmaCyte Stock, it is important to understand the factors that can impact its price. As of today, the current price of PharmaCyte Biotech stands at 1.76, as last reported on the 2nd of March, with the highest price reaching 1.84 and the lowest price hitting 1.70 during the day. At this point, PharmaCyte Biotech is dangerous. PharmaCyte Biotech maintains Sharpe Ratio (i.e., Efficiency) of 0.0196, which implies the firm had a 0.0196 % return per unit of risk over the last 3 months. We have found thirty technical indicators for PharmaCyte Biotech, which you can use to evaluate the volatility of the company. Please check PharmaCyte Biotech's Semi Deviation of 2.93, risk adjusted performance of 0.0225, and Coefficient Of Variation of 5055.48 to confirm if the risk estimate we provide is consistent with the expected return of 0.0687%.
PharmaCyte Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
PharmaCyte |
Sharpe Ratio = 0.0196
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | PMCB | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.5 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.07 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average PharmaCyte Biotech is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PharmaCyte Biotech by adding it to a well-diversified portfolio.
Related Headline
Instil Bio Headline on 4th of November 2024
Instil Bio, Inc.s stock price dropped 18 percent last week p... by simplywall.st
Key Insights The considerable ownership by private equity firms in Instil Bio indicates that they collectively have a...
PharmaCyte Biotech Valuation on November 4, 2024
It is possible to determine the worth of PharmaCyte Biotech on a given historical date. On November 4, 2024 PharmaCyte was worth 1.77 at the beginning of the trading date compared to the closed value of 1.74. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of PharmaCyte Biotech stock. Still, in general, we apply an absolute valuation method to find PharmaCyte Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of PharmaCyte Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against PharmaCyte Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 1.84 | 1.84 | 1.81 | 1.83 | 7,935 | |
11/04/2024 | 1.77 | 1.89 | 1.71 | 1.74 | 12,086 |
| 1.70 | 1.79 | 1.70 | 1.74 | 9,241 |
| Backtest PharmaCyte Biotech | | | PharmaCyte Biotech History | | | PharmaCyte Biotech Valuation | Previous | Next |
PharmaCyte Biotech Trading Date Momentum on November 4, 2024
| On November 05 2024 PharmaCyte Biotech was traded for 1.74 at the closing time. The top price for the day was 1.79 and the lowest listed price was 1.70 . The trading volume for the day was 9.2 K. The trading history from November 5, 2024 did not cause price change. The trading delta at closing time against the current closing price is 1.15% . |
PharmaCyte Biotech Fundamentals Correlations and Trends
By evaluating PharmaCyte Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among PharmaCyte Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. PharmaCyte financial account trend analysis is a perfect complement when working with valuation or volatility modules.About PharmaCyte Biotech Stock history
PharmaCyte Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for PharmaCyte is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in PharmaCyte Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing PharmaCyte Biotech stock prices may prove useful in developing a viable investing in PharmaCyte Biotech
PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada. Pharmacyte Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
PharmaCyte Biotech Stock Technical Analysis
PharmaCyte Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
PharmaCyte Biotech Period Price Range
Low | March 2, 2025
| High |
0.00 | 0.00 |
PharmaCyte Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
PharmaCyte Biotech March 2, 2025 Market Strength
Market strength indicators help investors to evaluate how PharmaCyte Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading PharmaCyte Biotech shares will generate the highest return on investment. By undertsting and applying PharmaCyte Biotech stock market strength indicators, traders can identify PharmaCyte Biotech entry and exit signals to maximize returns
PharmaCyte Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for PharmaCyte Biotech's price direction in advance. Along with the technical and fundamental analysis of PharmaCyte Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of PharmaCyte to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0225 | |||
| Jensen Alpha | 0.0745 | |||
| Total Risk Alpha | 0.1701 | |||
| Sortino Ratio | 0.0241 | |||
| Treynor Ratio | 0.0943 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for PharmaCyte Stock analysis
When running PharmaCyte Biotech's price analysis, check to measure PharmaCyte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PharmaCyte Biotech is operating at the current time. Most of PharmaCyte Biotech's value examination focuses on studying past and present price action to predict the probability of PharmaCyte Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PharmaCyte Biotech's price. Additionally, you may evaluate how the addition of PharmaCyte Biotech to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |